Close Menu

Harvard's Pamela Silver is studying cyanobacteria to figure out how to use them to produce fuel, but also for "a more fantastical use," reports Technology Review's blog. As Silver reported at a recent conference, her team inserted cyanobacteria that was labeled fluorescently into zebrafish embryos and watched the fish — and bacteria — grow. "When we put E. coli into fish, they blew up, but they are extremely tolerant of cynabacteria," Silver said, according to Tech Review.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.